The United Kingdom has seen cancer death rates fall to their lowest level on record, reflecting major long-term advances in prevention, diagnosis and treatment.
India has launched the world’s largest HPV vaccination programme, offering free jabs to around 11.5 million 14-year-old girls each year to prevent cervical cancer.
The United Kingdom has used a pioneering gene therapy that reprogrammes immune cells to hunt cancer, helping patients with previously untreatable blood cancer achieve lasting remission.
A new CRISPR-powered blood test can detect faint molecular signs of cancer in a drop of blood before tumors appear on scans, offering new possibilities for earlier diagnosis, scientists in China report.
In the UK, a breakthrough “living drug” has been given to an NHS patient with aggressive leukaemia, opening access to a powerful personalised therapy that can deliver long-term remission and potential cures.
In the United States, scientists have found that COVID-19 mRNA vaccines may do more than prevent infection — they could also strengthen cancer treatment.
Scientists have developed a new generation of immune cells that could transform cancer therapy. This breakthrough could make rapid, off-the-shelf treatments possible.
The World Health Organization has added vital treatments for cancer, diabetes, and obesity to its Essential Medicines Lists — a move that will make groundbreaking therapies more widely available worldwide.
Leukaemia, the most common cancer in children, is becoming less frequent worldwide. A major global study shows that between 1990 and 2021, childhood leukaemia rates steadily declined—bringing real progress in the fight against this disease.
New individualized cancer treatments are emerging, with the potential to revolutionize how patients receive care.
